Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques

Document Type : Research Articles

Authors

1 Radiation oncology department, Salah Azaiez Institute, Tunis, Tunisia. Faculty of medicine of Tunis, Tunis–el Manar University, Tunis, Tunisia.

2 Ophtalmology department, Hedi Raies Institute, Tunis, Tunisia. Faculty of medicine of Tunis, Tunis–el Manar University, Tunis, Tunisia.

3 Radiation oncology department, Salah Azaiez Institute, Tunis, Tunisia.

Abstract

 
Background: Brachytherapy is the most commonly used conservative treatment for the uveal melanoma. The aim of this study was to evaluate therapeutic results of Ruthenium-106 plaque brachytherapy in the management of localized uveal melanoma cases. Methods: We reviewed retrospectively the clinical records of all patients treated in our department for an uveal melanoma, undergoing Ruthenium-106 plaque brachytherapy, from January 1996 to December 2015. We focused on clinical features, therapeutic characteristics, local and distant tumor control and side effects. Results: Nineteen patients were enrolled in our study. Mean age was 56.2 years (28-79) and the sex ratio was 1.37:1 males to females. Diagnosis was made on the basis of ophthalmological clinical examination, angiography, ultrasound and/or magnetic resonance. Median tumor diameter was 9.7 mm (6-13) and median thickness 4.4 mm (2.5- 8). The dose of Ruthenium-106 plaque brachytherapy prescribed to the apex of each tumor was 70 Gy in all cases. The median radiation dose to the sclera surface was 226.4 Gy (range: 179.6–342.3) and the median total application time 115.2 hours (range: 27 to 237). After a median follow-up of 61.5 months, local control was achieved in 17 patients (89%): 16 demonstrated a partial tumor response and 1 tumor stabilization. Two patients suffered local progression leading to enucleation, one dying of hepatic metastasis. Radiation-induced complications were cataracts in 3 cases and vitreal hemorrhage in 2. Conclusion: Ruthenium-106 plaque brachytherapy is an efficient treatment for localized uveal melanoma, offering good local control with low toxicity.

Keywords

Asian Pacific Journal of Cancer Prevention
Volume 17, Issue 12
December 2016
Pages 5281-5285

Files

History

  • Receive Date: 28 November 2016
  • Revise Date: 20 December 2016
  • Accept Date: 25 January 2017

Share

How to cite

Statistics